Overview
Supporting You on the Path to Healing
A cancer diagnosis can be life-changing, but it’s never the end of the story. With the right support, information, and advances in modern medicine, there is always hope. We believe in possibilities: new options, new approaches, and better outcomes.
RGCC Cancer Tests
Understanding cancer is the first step towards making informed decisions about your health.
Today, there is a comprehensive range of cancer and chemosensitivity tests developed by RGCC, designed to provide healthcare professionals with valuable insights into the unique characteristics of each patient’s condition.
| About RGCC: Who Are They?
- RGCC (Research Genetic Cancer Centre) is an international group of laboratories specialising in advanced cancer diagnostics and research. By combining cutting-edge technology with ongoing scientific innovation, RGCC provides comprehensive testing and personalised solutions to support cancer care worldwide.
These tests draw on advanced technology and research to deliver detailed information about genetics, physiology,
and the immune system, helping to guide more personalised treatment plans.
Oncocount
Measures the presence and concentration of circulating tumor cells (CTCs) in the bloodstream.
Oncotrace
Identifies and characterises CTCs, including their immunophenotypes.
Oncotrail
Tailored testing for specific cancers such as breast, colon, gastrointestinal (GI), lungs, melanoma, prostate, and sarcoma.
Onconomics & Onconomics Plus
Analyses CTCs for chemosensitivity and epigenetic markers, with the “Plus” version incorporating natural extracts.
Immune-Frame
Assesses the patient’s immune status.
aCGH
Provides personalised chromosomal analysis.
Metastat
Helps determine the likelihood and potential location of secondary tumor spread.
CAMBISeq
Analyses over 500 oncogenes to support targeted drug selection.
Cancer Therapies
RGCC Cancer Therapies
Every patient’s journey with cancer is unique, and advances in medicine are making it increasingly possible to personalise treatment options. Around the world, RGCC is at the forefront of developing new approaches that aim to match therapies to the specific needs of each patient.
The field of Advanced Therapy Medicinal Products (ATMPs) continues to evolve, offering new possibilities in cancer care, especially for those seeking alternatives or complements to conventional treatments.
SOT (Supportive Oligonucleotide Therapy)
Uses specially designed oligonucleotide sequences intended to disrupt cancer cell survival or growth.
Dendritic Cell Therapy
A form of immunotherapy where dendritic cells are activated in the lab against certain peptides and then reintroduced to help the immune system better target cancer.
VAXO-Q-RE
Combines five types of immune cells, including macrophages, NK cells, dendritic cells, cytotoxic T-lymphocytes, and plasma cells for a more comprehensive immune response.
ATA (Autologous Tumor Antigen Vaccine)
Creates a personalised vaccine from fragments of the patient’s own tumor cells to help train the immune system.
These therapies highlight the direction of current scientific progress and the growing emphasis on individualised, evidence-based options in cancer treatment.
Medical Cannabis
Medical Cannabis and Cancer Care
Medical cannabis is an area of growing interest in cancer support, with ongoing research exploring its potential benefits for symptom management and quality of life. We have gathered a range of informational materials and guidance on this topic.
Let’s Take the Next Step Together
Have questions or need more details?
We’re here to support your health journey.
